Cardiovascular disease is the leading cause of death and death and disability, and contributes substantially to healthcare budgets. The lipid-lowering drugs, 3-hydroxy-3-methylgulutaryl –coenzyme A (HMG-CoA) reductase inhibitor or statins, reducing mortality and cardiovascular morbidity in patient with established cardiovascular disease. Stantins ttherefore have a place in the secondary preve…